TPG buys Actavis' contracting firm; Novella staffed up since Quintiles buyout;

> TPG closed its acquisition of Aptalis, Actavis' ($ACT) in-house R&D outsourcing company, rechristening it Adare Pharma. News

> IPCA Laboratories' Onyx Scientific is expanding its API manufacturing operation in the U.K. More

> Novella Clinical has added about 90 employees since Quintiles ($Q) bought it for $147 million in 2013. Item

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.